Trial Profile
A retrospective study to evaluate the occurrence of punctate pattern (PP) for diagnosis of progressive multifocal leukoencephalopathy (PML) related to natalizumab or not in patients with relapse remitting multiple sclerosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Apr 2016
Price :
$35
*
At a glance
- Drugs Natalizumab (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Pharmacodynamics
- 01 Apr 2016 New trial record
- 23 Mar 2016 Results published in the Neurology